AN OPEN MULTICENTER STUDY TO ASSESS THE LONG-TERM EFFICACY, TOLERANCE, AND SAFETY OF THE ORAL ANGIOTENSIN CONVERTING ENZYME-INHIBITOR RAMIPRIL IN PATIENTS WITH MILD TO MODERATE ESSENTIAL-HYPERTENSION

被引:11
作者
BAUER, B [1 ]
LORENZ, H [1 ]
ZAHLTEN, R [1 ]
机构
[1] BURO BIOMETRIE & STAT, NEUBERG, GERMANY
关键词
D O I
10.1097/00005344-198900133-00018
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S70 / S74
页数:5
相关论文
共 11 条
[1]  
BUNNING P, 1984, ARZNEIMITTEL-FORSCH, V34-2, P1406
[2]   EFFICACY AND INFLUENCE ON QUALITY-OF-LIFE OF ENALAPRIL AS A 1ST STEP TREATMENT OF HYPERTENSION [J].
CHATELLIER, G ;
SASSANO, P ;
AMIOT, AM ;
CORVOL, P ;
MENARD, J .
CLINICAL AND EXPERIMENTAL HYPERTENSION PART A-THEORY AND PRACTICE, 1987, 9 (2-3) :513-519
[3]   PRELIMINARY EXPERIENCES WITH HOE 498, A NOVEL LONG-ACTING CONVERTING-ENZYME-INHIBITOR, IN HYPERTENSIVE PATIENTS [J].
DELEEUW, PW ;
LUGTENBURG, PL ;
VANHOUTEN, H ;
LOOMAN, JHM ;
BIRKEHAGER, WH .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1985, 7 (06) :1161-1165
[4]  
FELDER K, 1984, ARZNEIMITTEL-FORSCH, V34-2, P1452
[5]  
GANTEN D, 1984, ARZNEIMITTEL-FORSCH, V34-2, P1391
[6]   IS TISSUE CONVERTING ENZYME-INHIBITION A DETERMINANT OF THE ANTIHYPERTENSIVE EFFICACY OF CONVERTING ENZYME-INHIBITORS - STUDIES WITH THE 2 DIFFERENT COMPOUNDS, HOE498 AND MK421, IN SPONTANEOUSLY HYPERTENSIVE RATS [J].
UNGER, T ;
GANTEN, D ;
LANG, RE ;
SCHOLKENS, BA .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1984, 6 (05) :872-880
[7]   EFFECT OF CONVERTING ENZYME-INHIBITORS ON TISSUE CONVERTING ENZYME AND ANGIOTENSIN-II - THERAPEUTIC IMPLICATIONS [J].
UNGER, T ;
GANTEN, D ;
LANG, RE .
AMERICAN JOURNAL OF CARDIOLOGY, 1987, 59 (10) :D18-D22
[8]  
VIDT DG, 1984, J HYPERTENSION S2, V2, P81
[9]  
WEINBERGER MH, 1982, BRIT J CLIN PHARMACO, V14, pS127, DOI 10.1111/j.1365-2125.1982.tb02069.x
[10]   COMPARATIVE DOUBLE-BLIND-STUDY OF RAMIPRIL AND CAPTOPRIL IN MILD TO MODERATE ESSENTIAL-HYPERTENSION [J].
WITTE, PU ;
WALTER, U .
AMERICAN JOURNAL OF CARDIOLOGY, 1987, 59 (10) :D115-D120